PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
Acute Coronary Syndromes 9,133 Disease Target Bivalirudin 891 167 0.06 -0.89 0.19 0.74
CCL2 3,560 Target Target CXCL10/IP-10 114 37 0.06 -0.82 0.32 0.75
CCL19 658 Target Target ELC 355 28 0.06 -0.94 0.08 0.80
AMAC-1 19 Target Target CCL18 256 4 0.06 -0.88 0.21 0.79
Epiregulin 291 Target Target EGF 27,487 162 0.06 -0.66 0.56 0.71
CXCL7 76 Target Target CCL8 197 7 0.06 -0.94 0.09 0.81
CCL5 2,002 Target Target CXCL10/IP-10 114 27 0.06 -0.87 0.24 0.76
EPHB3 118 Target Target EPHA3 140 7 0.05 -0.95 0.06 0.82
CXCL7 76 Target Target CXCL2 750 13 0.05 -0.90 0.17 0.78
Diabetes 332,602 Disease Target Adiponectin 11,994 3,433 0.05 -0.84 0.29 0.66
Epidermal Growth Factor Receptor 24,772 Target Target ERBB3 1,154 289 0.05 -0.86 0.25 0.72
Carcinoma 433,099 Disease Target AFP 9,751 3,499 0.05 -0.80 0.36 0.66
Leukemia 162,805 Disease Target CD34 24,598 3,403 0.05 -0.92 0.14 0.68
CCL18 256 Target Target CCL14 34 5 0.05 -0.91 0.15 0.79
Phospholipase A2 13,400 Target Target Platelet Activating Factor 9,915 614 0.05 -0.95 0.06 0.75
CCL2 3,560 Target Target CXCL3 145 38 0.05 -0.85 0.26 0.75
CCL8 197 Target Target CCL1 220 11 0.05 -0.95 0.06 0.81
CXCL11 526 Target Target CCL8 197 17 0.05 -0.94 0.09 0.79
Angiotensin-Converting Enzyme 2 665 Target Target Renin 43,456 283 0.05 -0.76 0.43 0.70
CD22 1,591 Target Target CD72 198 29 0.05 -0.92 0.15 0.77
Thromboembolism 23,698 Disease Target Antithrombin 13,773 929 0.05 -0.95 0.07 0.73
CCL5 2,002 Target Target CCL1 220 34 0.05 -0.91 0.15 0.76
CD68 6,424 Target Target CD14 9,941 408 0.05 -0.95 0.06 0.75
Ventricular Dysfunction 12,856 Disease Target BNP 6,842 477 0.05 -0.95 0.07 0.74
EPHB4 329 Target Target EPHA2 532 21 0.05 -0.95 0.06 0.80
CCL7 274 Target Target CXCL3 145 10 0.05 -0.95 0.07 0.80
Platelet Aggregation 25,460 Disease Target Platelet Activating Factor 9,915 783 0.05 -0.94 0.08 0.73
744.1 22 Target Target 464.1 19 1 0.05 -0.95 0.05 0.83
Cathepsin G 1,613 Target Target Alpha-1 AntiChymotrypsin 1,460 75 0.05 -0.95 0.05 0.78
CAMK2A 42 Target Target ADRBK1 10 1 0.05 -0.94 0.10 0.81
EPHA4 357 Target Target EPHB3 118 10 0.05 -0.94 0.08 0.79
Draflazine 33 Drug Target Equilibrative Nucleoside Transporter 1 211 4 0.05 -0.93 0.12 0.79
CXCL16 341 Target Target CXCL10 2,386 43 0.05 -0.93 0.13 0.76
EPHA2 532 Target Target EPHA3 140 13 0.05 -0.94 0.09 0.78
Adenosine A3 Receptor 164 Target Target Adenosine A1 Receptor 1,432 23 0.05 -0.92 0.14 0.76
Exodus-2 27 Target Target CCL21 808 7 0.05 -0.86 0.26 0.76
EPHA3 140 Target Target EPHB2 385 11 0.05 -0.95 0.08 0.79
CXCL9 1,016 Target Target CCL8 197 21 0.05 -0.94 0.11 0.77
Carcinoma 433,099 Disease Target CEA 17,022 4,013 0.05 -0.87 0.24 0.65
Epigen 27 Target Target beta-Cellulin 17 1 0.05 -0.95 0.06 0.83
CCL3 1,427 Target Target CXCL3 145 21 0.05 -0.92 0.14 0.76
Erbb2 4,536 Target Target EGF 27,487 513 0.05 -0.93 0.11 0.72
CCL7 274 Target Target CXCL9 1,016 24 0.05 -0.94 0.09 0.77
CCL19 658 Target Target CCL5 2,002 52 0.05 -0.95 0.08 0.77
ELC 355 Target Target DC-CK1 22 4 0.05 -0.90 0.18 0.77
A1M 59 Target Target B2M 677 9 0.05 -0.91 0.15 0.77
CCL4 5,638 Target Target CXCL10 2,386 165 0.04 -0.95 0.07 0.75
CD146 729 Target Target CD34 24,598 190 0.04 -0.86 0.26 0.71
Myeloperoxidase 16,181 Target Target Elastase 13,875 671 0.04 -0.96 0.05 0.74
CCL18 256 Target Target CCL3 1,427 27 0.04 -0.94 0.11 0.76